Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1892 1
2009 4
2010 8
2011 2
2012 4
2013 7
2014 7
2015 11
2016 10
2017 11
2018 14
2019 11
2020 13
2021 12
2022 10
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 24688754

114 results

Results by year

Filters applied: . Clear all
Page 1
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
Onken JE, Bregman DB, Harrington RA, Morris D, Buerkert J, Hamerski D, Iftikhar H, Mangoo-Karim R, Martin ER, Martinez CO, Newman GE, Qunibi WY, Ross DL, Singh B, Smith MT, Butcher A, Koch TA, Goodnough LT. Onken JE, et al. Nephrol Dial Transplant. 2014 Apr;29(4):833-42. doi: 10.1093/ndt/gft251. Epub 2013 Aug 20. Nephrol Dial Transplant. 2014. PMID: 23963731 Clinical Trial.
A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
Khalafallah AA, Hyppa A, Chuang A, Hanna F, Wilson E, Kwok C, Yan C, Gray Z, Mathew R, Falloon P, Dennis A, Pavlov T, Allen JC. Khalafallah AA, et al. Semin Hematol. 2018 Oct;55(4):223-234. doi: 10.1053/j.seminhematol.2018.04.006. Epub 2018 Apr 25. Semin Hematol. 2018. PMID: 30502851 Clinical Trial.
TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
Schatz U, Illigens BM, Siepmann T, Arneth B, Siegert G, Siegels D, Heigl F, Hettich R, Ramlow W, Prophet H, Bornstein SR, Julius U. Schatz U, et al. Atheroscler Suppl. 2015 May;18:199-208. doi: 10.1016/j.atherosclerosissup.2015.02.030. Atheroscler Suppl. 2015. PMID: 25936327
114 results